NEJM Evidence has published two letters to the editor that raised questions about our meta-analysis, Population-Based Disease Odds for E-Cigarettes and Dual Use versus Cigarettes that concluded that for cardiovascular disease, stroke and metabolic disorder e-cigarette risks are similar to cigarettes and for respiratory and oral disease, while lower risk than cigarettes, the risks areContinue reading “Criticism of our meta-analysis of e-cigarettes and disease and our response is published”
Author Archives: Stanton Glantz
DOJ and DEA should reclassify marijuana from Schedule I to Schedule III to identify regulatory approaches from tobacco to apply to cannabis
My UCSF colleagues and I submitted this comment to DOJ supporting reschduling marijuana from Schedule I to Schedule III ( PDF). The regulations.gov tracking number is lyx-h4jq-93z8. The Department of Justice and Drug Enforcement Agency should reclassify marijuana from Schedule I to Schedule III to allow consideration of the health, safety, and abuse liability impactsContinue reading “DOJ and DEA should reclassify marijuana from Schedule I to Schedule III to identify regulatory approaches from tobacco to apply to cannabis”
DOJ’s proposed transfer of marijuana from Schedule I to Schedule III will facilitate research on cardiovascular impacts of cannabis use
My UCSF colleagues and I just submitted this public comment supporting moving marijuana from Schedule I to Schedule III (PDF copy). The Regulations.gov tracking number is lyx-h4jq-93z8. The Department of Justice’s proposed transfer of marijuana from Schedule I to Schedule III of the Controlled Substances Act will facilitate research on the cardiovascular impacts of cannabisContinue reading “DOJ’s proposed transfer of marijuana from Schedule I to Schedule III will facilitate research on cardiovascular impacts of cannabis use”
New meta-analysis of e-cigs and cardiovascular disease shows increased risks
Chen Chen and colleagues recently published Assessing the association between e-cigarette use and cardiovascular disease: A meta-analysis of exclusive and dual use with combustible cigarettes that found significantly elevated cardiovascular disease risk in dual users (people who use both e-cigarettes and cigarettes) and former smokers who had switched to e-cigarettes compared to people who hadContinue reading “New meta-analysis of e-cigs and cardiovascular disease shows increased risks”
Tobacco free generation is a bad idea that should be abandoned
In the last few years the idea of a free generation in which tobacco sales would be prohibited to all people born after a certain date has gained some traction. Ever since the idea was first proposed by some Singapore researchers in 2010, I have thought it was a bad idea. Other than declining toContinue reading “Tobacco free generation is a bad idea that should be abandoned”
Smoking gun document ties Al Sharpton to Juul, efforts to protect menthol cigs
Fenit Nirappil’s comprehensive Washington Post story How Black activists became defenders of Big Tobacco (June 21, 2024) includes the 2018 smoking gun document linking Al Sharpton the African American leader who played a key role in convincing Biden to pull FDA regulations ending menthol cigarettes and flavored cigars, as well as other African American andContinue reading “Smoking gun document ties Al Sharpton to Juul, efforts to protect menthol cigs”
UCSF makes 299k Juul documents public on the internet; more to come
On June 27. 20-24 the UCSF Industry Documents Library added of 289,868 new JUUL Labs documents to the Truth Tobacco Industry Documents Library, bringing the total number of publicly available previously secret Juul documents to 1,870,542. There are about 2 million Juul documents from the North Carolina settlement to be loaded plus another about 2Continue reading “UCSF makes 299k Juul documents public on the internet; more to come”
Shocking FDA TPSAC Meeting on PMI General Snus modified risk application
I spoke at the FDA Tobacco Products Scientific Advisory Committee meeting held yesterday (June 26, 2024) to consider Philip Morris International’s (PMI) Modified Risk Tobacco Product (MRTP) application to renew authorization to make modified (read “reduced”) risk claims about its Swedish Match General Snus. I expected the meeting to end with TPSAC voting on aContinue reading “Shocking FDA TPSAC Meeting on PMI General Snus modified risk application”
FDA should consider the significant public health issues, especially for youth, created by PMI co-marketing of its Swedish Match General Snus and ZYN oral nicotine products and not reauthorize modified risk claims for General Snus
My colleagues at UCSF and I submitted this comment to the FDA Tobacco Products Scientific Advisory Committee opposing extension of PMI’s current authorization to make modified risk claims because its co-marketing with its ZYN nicotine pouch is fundamentally misleading. TPSAC is holding a meeting to discuss the modified risk request on June 26, 2024. AContinue reading “FDA should consider the significant public health issues, especially for youth, created by PMI co-marketing of its Swedish Match General Snus and ZYN oral nicotine products and not reauthorize modified risk claims for General Snus”
FDA should not renew its authorization allowing PMI to claim modified risk for its Swedish Match General Snus
My colleagues at UCSF and Stanford and I submitted this comment to the FDA Tobacco Products Scientific Advisory Committee opposing extension of PMI’s current authorization to make modified risk claims. (The committee is holding a meeting to discuss the application on June 26, 2004.) A PDF of the comment is here. (It will be submittedContinue reading “FDA should not renew its authorization allowing PMI to claim modified risk for its Swedish Match General Snus”
Stanton Glantz blog 